SMS Pharmaceuticals Limited (SMSPHARMA.BO)
SMS Pharmaceuticals Limited operates in the Drug Manufacturers - General industry of the Healthcare sector, headquartered in Hyderabad, TS, IN. The stock last traded at $360.55, down 1.53% on the session, giving a market capitalisation of $33.81B. Its beta of 1.15 implies it has historically moved more than the broad market.
SMS Pharmaceuticals Limited, an India-based entity, specializes in the production and commercialization of active pharmaceutical ingredients (APIs) and related intermediates. The company's extensive product portfolio addresses various therapeutic areas, such as anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, anti-epileptic, anti-psychotic, anti-inflammatory, anti-viral, anti-coagulant, and anti-retroviral treatments. In addition to its manufacturing activities, the firm engages in contract research. Established in 1987 and headquartered in Hyderabad, India, SMS Pharmaceuticals Limited not only supplies the domestic market but also ships its products globally.
SMS Pharmaceuticals Limited is most often compared with the following Healthcare names: